Literature DB >> 97230

Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.

G A Schmuñis, A Szarfman, T Langembach, W de Souza.   

Abstract

The effect of human-specific antibody on surface membrane antigens of trypomastigotes of Trypanosoma cruzi was studied in vitro by using immunofluorescence methods. Immune sera induced aggregation of surface antigens in trypomastigotes to form polar cell caps.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97230      PMCID: PMC421891          DOI: 10.1128/iai.20.2.567-569.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Antibody-induced movement of protozoan surface membrane antigens.

Authors:  J J Doyle; R Behin; J Mauel; D S Rowe
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

2.  Endocytosis by lymphocytes of complexes of anti-Ig with membrane-bound Ig.

Authors:  E R Unanue; W D Perkins; M J Karnovsky
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

3.  Humoral antibody response and Ig characterization of the specific agglutinins in rabbits during experimental American trypanosomiasis.

Authors:  S M Gonzales Cappa; N H Vattuone; S Menes; G A Schmuñis
Journal:  Exp Parasitol       Date:  1973-08       Impact factor: 2.011

4.  [Value of xenodiagnosis in chronic Chagasic infection].

Authors:  H Schenone; E Alfaro; H Reyes; E Taucher
Journal:  Bol Chil Parasitol       Date:  1968 Oct-Dec

5.  Cross-reactivity of lytic antibodies against blood forms of Trypanosoma cruzi.

Authors:  F Kierszenbaum
Journal:  J Parasitol       Date:  1976-02       Impact factor: 1.276

6.  Electron microscopic and radioisotopic studies on cap formation in Toxoplasma gondii.

Authors:  T H Dzbenski; T Michalak; W S Plonka
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

7.  Immunologic studies on Trypanosoma cruzi. III. Duration of acquired immunity in mice initially infected with a North American strain of T. cruzi.

Authors:  I G KAGAN; L NORMAN
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

8.  Antibody-induced modulation of Leishmania donovani surface membrane antigens.

Authors:  D M Dwyer
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

9.  Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Authors:  D B Budzko; M C Pizzimenti; F Kierszenbaum
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

10.  Immunological studies in Rockland mice infected with T. cruzi. Development of antinuclear antibodies.

Authors:  A Szarfman; P M Cossio; R P Laguens; A Segal; M T De La Vega; R M Arana; G A Schmuñis
Journal:  Biomedicine       Date:  1975-11
View more
  6 in total

1.  Trypanosoma cruzi glycoprotein 72: immunological analysis and cellular localization.

Authors:  G Harth; A A Mills; T Souto-Padrón; W de Souza
Journal:  Mol Cell Biochem       Date:  1992-01-15       Impact factor: 3.396

2.  Antibody-induced capping of the intracellular stage of Trypanosoma cruzi.

Authors:  W Leon; F Villalta; T Queiroz; A Szarfman
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

3.  Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.

Authors:  A U Krettli; L C Pontes de Carvalho
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.

Authors:  K A Norris; J E Schrimpf; M J Szabo
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

6.  Antibodies to laminin in Chagas' disease.

Authors:  A Szarfman; V P Terranova; S I Rennard; J M Foidart; M de Fatima Lima; J I Scheinman; G R Martin
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.